Birmingham Hip Resurfacing: a retrospective cohort study of clinical, biochemical, and radiological outcomes in a non-designer centre at minimum 15 years’ follow-up

Aims: Although the use of metal-on-metal (MoM) implants in total hip arthroplasty (THA) remains a topic of controversy, prior literature has reported satisfactory ten-year clinical and radiological outcomes following Birmingham Hip Resurfacing (BHR), subsequently resulting in a recent Orthopaedic D...

Full description

Saved in:
Bibliographic Details
Main Authors: Martin S. Davey, Conor Farrell, Conor Kilkenny, Conor Medlar, Niall P. McGoldrick, John F. Quinlan
Format: Article
Language:English
Published: The British Editorial Society of Bone & Joint Surgery 2025-04-01
Series:Bone & Joint Open
Subjects:
Online Access:https://online.boneandjoint.org.uk/doi/epdf/10.1302/2633-1462.64.BJO-2025-0003.R1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850140510495178752
author Martin S. Davey
Conor Farrell
Conor Kilkenny
Conor Medlar
Niall P. McGoldrick
John F. Quinlan
author_facet Martin S. Davey
Conor Farrell
Conor Kilkenny
Conor Medlar
Niall P. McGoldrick
John F. Quinlan
author_sort Martin S. Davey
collection DOAJ
description Aims: Although the use of metal-on-metal (MoM) implants in total hip arthroplasty (THA) remains a topic of controversy, prior literature has reported satisfactory ten-year clinical and radiological outcomes following Birmingham Hip Resurfacing (BHR), subsequently resulting in a recent Orthopaedic Data Evaluation Panel (ODEP) rating of 15 A*. Therefore, the purpose of this study was to evaluate the functional outcomes, radiological outcomes, and revision rates following BHR at a minimum of 15 years’ follow-up in a non-designer centre. Methods: Two investigators performed a retrospective review to identify consecutive patients who underwent BHR in our institution over a seven-year period (2003 to 2009, at minimum 15 years’ follow-up) in a non-designer centre. Evaluation of clinical (Oxford Hip Scores (OHS)), biochemical (cobalt and chromium levels), and radiological (plain film radiographs) outcomes was carried out. Survivorship analysis was performed using Kaplan-Meier curves, with all-cause surgical revision defined as a definitive endpoint for analysis. Descriptive statistical analysis was carried out. Results: Overall, 96 patients (86 males) at a mean age of 51.4 years (SD 9.9; 27 to 69) underwent 105 BHR procedures (nine bilateral) with at least 15 years’ minimum follow-up. Mean OHS was 38.3 (SD 9.6; 17 to 48) at 15-year minimum follow-up. The overall survivorship was 94.3% at 15 years post BHR, with an all-cause revision rate of 5.7%. Only eight BHR prostheses (8.2%) had radiolucent lines on plain films, none of which were listed for revision at the time of latest follow-up, while 32 patients had undergone MRI at 170 months (SD 54.9; 6 to 249) post BHR, with evidence of fluid collection, aseptic lymphocyte-dominant vasculitis-associated lesion, and metallosis identified on the MRI of four patients, four patients, and one patient, respectively. For 98.4% (60/61) of patients, cobalt and chromium values were either within normal limits (68.9%, n = 42) or less than double the upper limit of normal (29.5%, n = 18). Conclusion: This study found that BHR demonstrates an acceptable survivorship of 94% at 15 years of minimum follow-up, with satisfactory clinical and radiological outcomes to reflect this low all-cause revision rate in a non-designer centre. Cite this article: Bone Jt Open 2025;6(4):413–418.
format Article
id doaj-art-b4982614df4647e782f71f3c843a219f
institution OA Journals
issn 2633-1462
language English
publishDate 2025-04-01
publisher The British Editorial Society of Bone & Joint Surgery
record_format Article
series Bone & Joint Open
spelling doaj-art-b4982614df4647e782f71f3c843a219f2025-08-20T02:29:46ZengThe British Editorial Society of Bone & Joint SurgeryBone & Joint Open2633-14622025-04-016441341810.1302/2633-1462.64.BJO-2025-0003.R1Birmingham Hip Resurfacing: a retrospective cohort study of clinical, biochemical, and radiological outcomes in a non-designer centre at minimum 15 years’ follow-upMartin S. Davey0Conor Farrell1Conor Kilkenny2Conor Medlar3Niall P. McGoldrick4John F. Quinlan5Tallaght University Hospital, Dublin, IrelandTallaght University Hospital, Dublin, IrelandTallaght University Hospital, Dublin, IrelandTallaght University Hospital, Dublin, IrelandTallaght University Hospital, Dublin, IrelandTallaght University Hospital, Dublin, IrelandAims: Although the use of metal-on-metal (MoM) implants in total hip arthroplasty (THA) remains a topic of controversy, prior literature has reported satisfactory ten-year clinical and radiological outcomes following Birmingham Hip Resurfacing (BHR), subsequently resulting in a recent Orthopaedic Data Evaluation Panel (ODEP) rating of 15 A*. Therefore, the purpose of this study was to evaluate the functional outcomes, radiological outcomes, and revision rates following BHR at a minimum of 15 years’ follow-up in a non-designer centre. Methods: Two investigators performed a retrospective review to identify consecutive patients who underwent BHR in our institution over a seven-year period (2003 to 2009, at minimum 15 years’ follow-up) in a non-designer centre. Evaluation of clinical (Oxford Hip Scores (OHS)), biochemical (cobalt and chromium levels), and radiological (plain film radiographs) outcomes was carried out. Survivorship analysis was performed using Kaplan-Meier curves, with all-cause surgical revision defined as a definitive endpoint for analysis. Descriptive statistical analysis was carried out. Results: Overall, 96 patients (86 males) at a mean age of 51.4 years (SD 9.9; 27 to 69) underwent 105 BHR procedures (nine bilateral) with at least 15 years’ minimum follow-up. Mean OHS was 38.3 (SD 9.6; 17 to 48) at 15-year minimum follow-up. The overall survivorship was 94.3% at 15 years post BHR, with an all-cause revision rate of 5.7%. Only eight BHR prostheses (8.2%) had radiolucent lines on plain films, none of which were listed for revision at the time of latest follow-up, while 32 patients had undergone MRI at 170 months (SD 54.9; 6 to 249) post BHR, with evidence of fluid collection, aseptic lymphocyte-dominant vasculitis-associated lesion, and metallosis identified on the MRI of four patients, four patients, and one patient, respectively. For 98.4% (60/61) of patients, cobalt and chromium values were either within normal limits (68.9%, n = 42) or less than double the upper limit of normal (29.5%, n = 18). Conclusion: This study found that BHR demonstrates an acceptable survivorship of 94% at 15 years of minimum follow-up, with satisfactory clinical and radiological outcomes to reflect this low all-cause revision rate in a non-designer centre. Cite this article: Bone Jt Open 2025;6(4):413–418.https://online.boneandjoint.org.uk/doi/epdf/10.1302/2633-1462.64.BJO-2025-0003.R1birminghamhip resurfacinglong-term15 yearsnon-designer centrebirmingham hip resurfacingradiological outcomesmris scansoxford hip scores (ohs)chromiumcobaltfunctional outcomesradiolucent linesradiographsmetallosis
spellingShingle Martin S. Davey
Conor Farrell
Conor Kilkenny
Conor Medlar
Niall P. McGoldrick
John F. Quinlan
Birmingham Hip Resurfacing: a retrospective cohort study of clinical, biochemical, and radiological outcomes in a non-designer centre at minimum 15 years’ follow-up
Bone & Joint Open
birmingham
hip resurfacing
long-term
15 years
non-designer centre
birmingham hip resurfacing
radiological outcomes
mris scans
oxford hip scores (ohs)
chromium
cobalt
functional outcomes
radiolucent lines
radiographs
metallosis
title Birmingham Hip Resurfacing: a retrospective cohort study of clinical, biochemical, and radiological outcomes in a non-designer centre at minimum 15 years’ follow-up
title_full Birmingham Hip Resurfacing: a retrospective cohort study of clinical, biochemical, and radiological outcomes in a non-designer centre at minimum 15 years’ follow-up
title_fullStr Birmingham Hip Resurfacing: a retrospective cohort study of clinical, biochemical, and radiological outcomes in a non-designer centre at minimum 15 years’ follow-up
title_full_unstemmed Birmingham Hip Resurfacing: a retrospective cohort study of clinical, biochemical, and radiological outcomes in a non-designer centre at minimum 15 years’ follow-up
title_short Birmingham Hip Resurfacing: a retrospective cohort study of clinical, biochemical, and radiological outcomes in a non-designer centre at minimum 15 years’ follow-up
title_sort birmingham hip resurfacing a retrospective cohort study of clinical biochemical and radiological outcomes in a non designer centre at minimum 15 years follow up
topic birmingham
hip resurfacing
long-term
15 years
non-designer centre
birmingham hip resurfacing
radiological outcomes
mris scans
oxford hip scores (ohs)
chromium
cobalt
functional outcomes
radiolucent lines
radiographs
metallosis
url https://online.boneandjoint.org.uk/doi/epdf/10.1302/2633-1462.64.BJO-2025-0003.R1
work_keys_str_mv AT martinsdavey birminghamhipresurfacingaretrospectivecohortstudyofclinicalbiochemicalandradiologicaloutcomesinanondesignercentreatminimum15yearsfollowup
AT conorfarrell birminghamhipresurfacingaretrospectivecohortstudyofclinicalbiochemicalandradiologicaloutcomesinanondesignercentreatminimum15yearsfollowup
AT conorkilkenny birminghamhipresurfacingaretrospectivecohortstudyofclinicalbiochemicalandradiologicaloutcomesinanondesignercentreatminimum15yearsfollowup
AT conormedlar birminghamhipresurfacingaretrospectivecohortstudyofclinicalbiochemicalandradiologicaloutcomesinanondesignercentreatminimum15yearsfollowup
AT niallpmcgoldrick birminghamhipresurfacingaretrospectivecohortstudyofclinicalbiochemicalandradiologicaloutcomesinanondesignercentreatminimum15yearsfollowup
AT johnfquinlan birminghamhipresurfacingaretrospectivecohortstudyofclinicalbiochemicalandradiologicaloutcomesinanondesignercentreatminimum15yearsfollowup